Effect of BRD4 Inhibitor on Cognitive Deficit and c-Fos /BDNF level in rats with Alzheimer's disease

[1]  J. García-Estrada,et al.  Immediate Early Gene c-fos in the Brain: Focus on Glial Cells , 2022, Brain sciences.

[2]  P. Babaei,et al.  Effects of inhibiting astrocytes and BET/BRD4 chromatin reader on spatial memory and synaptic proteins in rats with Alzheimer’s disease , 2022, Metabolic Brain Disease.

[3]  S. Fakhri,et al.  Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach. , 2022, Pharmacological research.

[4]  P. Babaei,et al.  Simultaneous administration of bromodomain and histone deacetylase I inhibitors alleviates cognition deficit in Alzheimer's model of rats , 2021, Brain Research Bulletin.

[5]  L. Duffy,et al.  Role of Receptors in Relation to Plaques and Tangles in Alzheimer’s Disease Pathology , 2021, International journal of molecular sciences.

[6]  W. Bilecki,et al.  Inhibition of BET Proteins during Adolescence Affects Prefrontal Cortical Development: Relevance to Schizophrenia , 2021, International journal of molecular sciences.

[7]  Demian Battaglia,et al.  Early memory deficits and extensive brain network disorganization in the AppNL-F/MAPT double knock-in mouse model of familial Alzheimer’s disease , 2021, bioRxiv.

[8]  Yong-Ku Kim,et al.  CREB and BDNF: Neurobiology and treatment of Alzheimer's disease. , 2020, Life sciences.

[9]  Manhua Liu,et al.  A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer’s disease , 2019, NeuroImage.

[10]  Amanda J. Kedaigle,et al.  Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice. , 2019, Human molecular genetics.

[11]  Hyundong Song,et al.  Amyloid β‐induced elevation of O‐GlcNAcylated c‐Fos promotes neuronal cell death , 2018, Aging cell.

[12]  J. Medina,et al.  Immediate Early Genes, Memory and Psychiatric Disorders: Focus on c-Fos, Egr1 and Arc , 2018, Front. Behav. Neurosci..

[13]  P. Babaei,et al.  Vitamin D is associated with metabotropic but not neurotrophic effects of exercise in ovariectomized rats , 2017, Diabetology & Metabolic Syndrome.

[14]  A. Fischer,et al.  The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice , 2017, Translational Psychiatry.

[15]  T. Rantamäki,et al.  Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[16]  D. Bennett,et al.  Reduced pCREB in Alzheimer's disease prefrontal cortex is reflected in peripheral blood mononuclear cells , 2016, Molecular Psychiatry.

[17]  A. Tarakhovsky,et al.  Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice , 2015, The Journal of experimental medicine.

[18]  R. Darnell,et al.  BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice , 2015, Nature Neuroscience.

[19]  G. Quirk,et al.  Persistent active avoidance correlates with activity in prelimbic cortex and ventral striatum , 2015, Front. Behav. Neurosci..

[20]  Lief E. Fenno,et al.  Chronic optogenetic activation augments Aβ pathology in a mouse model of Alzheimer disease , 2022 .

[21]  Cassandra D. Leonardo,et al.  Comparison of nine tractography algorithms for detecting abnormal structural brain networks in Alzheimer’s disease , 2015, Front. Aging Neurosci..

[22]  M. Porcionatto,et al.  The pattern of c-Fos expression and its refractory period in the brain of rats and monkeys , 2015, Front. Cell. Neurosci..

[23]  L. Tan,et al.  Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy , 2015, Molecular Neurobiology.

[24]  D. Reinberg,et al.  BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones , 2014, Nature Structural &Molecular Biology.

[25]  Junwei Shi,et al.  The mechanisms behind the therapeutic activity of BET bromodomain inhibition. , 2014, Molecular cell.

[26]  Bradley T. Hyman,et al.  The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease , 2014, Neuron.

[27]  Zhaohui S. Qin,et al.  Therapeutic Targeting of BET Bromodomain Proteins in Castration-Resistant Prostate Cancer , 2014, Nature.

[28]  S. Knapp,et al.  Targeting bromodomains: epigenetic readers of lysine acetylation , 2014, Nature Reviews Drug Discovery.

[29]  P. Hof,et al.  Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients , 2013, Neurobiology of Aging.

[30]  Saptarsi M. Haldar,et al.  BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure , 2013, Cell.

[31]  David A. Orlando,et al.  Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.

[32]  H. Varmus,et al.  Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins , 2012, Proceedings of the National Academy of Sciences.

[33]  G. Brewer,et al.  Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer’s disease , 2013, AGE.

[34]  M. Roghani,et al.  Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress , 2011, Behavioural Brain Research.

[35]  R. Young,et al.  BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.

[36]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[37]  C. Kruse,et al.  Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. , 2010, Brain : a journal of neurology.

[38]  William B. Smith,et al.  Selective inhibition of BET bromodomains , 2010, Nature.

[39]  Steven Mennerick,et al.  Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.

[40]  J. Wuu,et al.  Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease , 2005, Journal of neurochemistry.

[41]  J. Medina,et al.  ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. , 2004, Learning & memory.

[42]  M. Sofroniew,et al.  Nerve growth factor signaling, neuroprotection, and neural repair. , 2001, Annual review of neuroscience.

[43]  S. Estus,et al.  c‐Jun Contributes to Amyloid β‐Induced Neuronal Apoptosis but Is Not Necessary for Amyloid β‐Induced c‐jun Induction , 1999 .

[44]  N. Sakai,et al.  c-Fos expression in the parabrachial nucleus after ingestion of sodium chloride in the rat. , 1993, Neuroreport.

[45]  Richard J Smeyne,et al.  Continuous c-fos expression precedes programmed cell death in vivo , 1993, Nature.